Estimating the Effects of Pharmaceutical Innovations on Patients' Employment Outcomes

by Yuhua Bao

Full Document

Full Document

FormatFile SizeNotes
PDF file 0.5 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

Summary Only

FormatFile SizeNotes
PDF file 0.1 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

In recent years, advances in medical technologies have been a major source of the increasing cost of health care in the United States. Society and policymakers must increasingly make hard choices when allocating limited resources among competing uses, and evaluating the benefits and costs of new technologies is becoming more urgent. However, current approaches to evaluating the benefits of medical technologies often ignore employment-related benefits, thus undervaluing interventions that improve functioning and productivity among the working-age population. This dissertation reviews evidence of employment-related benefits resulting from effective treatment. The author developed a model showing that the observed incremental labor supply is a result both of more-effective treatment and of other factors such as eligibility for employment-based or public health insurance, both of which are tied to employment status. She then conducted two empirical studies to estimate the employment effects of treatment-one on the effect of Highly Active Antiretroviral Therapy on HIV patients' employment transitions, the other on the effect of recent improvements in pharmacological therapies for hypertension. The author concludes that when translating estimated employment effects into employment-related benefits, one must be aware of possible labor market adjustments associated with the change and base the analysis on labor market equilibria.

Table of Contents

  • Chapter One


  • Chapter Two

    Employment Effects of Pharmaceutical Innovations: A Microeconomic Model and a Critique of Previous Approaches

  • Chapter Three

    Effective HIV Treatment and the Employment of HIV+ Adults

  • Chapter Four

    Recent Drug Therapies for High Blood Pressure: Do They Help People Work More

  • Chapter Five

    Discussion and Conclusions

Research conducted by

This report is part of the RAND Corporation Dissertation series. Pardee RAND dissertations are produced by graduate fellows of the Pardee RAND Graduate School, the world's leading producer of Ph.D.'s in policy analysis. The dissertations are supervised, reviewed, and approved by a Pardee RAND faculty committee overseeing each dissertation.

Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.